As our label-free technologies perform drug-target MoA under physiological environments and in human samples, the test compound preserves its original structure as well as the exact same molecular structure that would be used in therapy.
Identify the mode of action of your compound
From preclinical to clinical
Adopt a robust solution that can ensure the success of your Phase II study and accompany you in achieving the success of your drug candidate in Phase III
Identify a cohort of patients responding to your therapy